Fidelity SPDR Advertisement
Home > Boards > Free Zone > Health and Sciences > Biotech Values

HEB’s insiders are looting the company:

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
DewDiligence Member Profile
Member Level 
Followed By 484
Posts 81,447
Boards Moderated 21
Alias Born 09/05/02
160x600 placeholder
U.S. Stocks: Futures Climb; 3M, GM Results On Tap
Wall Street was looking at a higher open on Thursday, with U.S. stock futures strengthening after key eurozone data came in better than anticipated. The deluge of corporate results will continue, with industrial conglomerate 3M Co. expected to report a rise in quarterly earnings.
Top Equities Stories Of The Day
Hong Kong Protests Expose Differences in Local Media
FTSE 100 Climbs As Oil Stocks Advance
Safran Revenue Rises on Sustained Demand for Jet Engines
Correction to AT&T Earnings Preview Story
Five HP Executives Sell $12.3 Million in Stock -- Barron's
Stifel Financial to Hire Two Former Merrill Lynch Advisers
Nokia Outlook Bullish As It Swings to Profit
U.S. Stocks Gain, but IBM Weighs on Dow
DewDiligence Member Level  Tuesday, 06/02/09 06:08:42 PM
Re: exwannabe post# 78906
Post # of 183119 
HEB’s insiders are looting the company:

While pumpers are mindlessly pumping HEB on various message boards, officers and directors have been engaged in a game of their own: systematically looting the company to the greatest extent possible. Last week, without even waiting for FDA action on the Ampligen BLA, HEB paid the CEO a $300K bonus and the CMO a $150K bonus (#msg-38179694).

The BoD had the audacity to grant these bonuses despite the fact that HEB cut the salaries of its non-executive employees in Jan 2009. Despite the fact that the CEO received more than $1M in compensation in 2008. Despite the fact that the CEO received almost $3M in compensation in 2007.

Want more? HEB pays each non-employee director $150K per annum merely to attend board meetings! You can find these and other details in the recent DEF14A filing: http://sec.gov/Archives/edgar/data/946644/000114420409029059/v150612_def14a.htm .

I shudder to think how much insiders will pay themselves if by some miracle the FDA actually approves Ampligen.


“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (2) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist